Doctor profile · Federal record
Dr. JESSICA LABADIE, MD
Dermatology Physician (CMS: DERMATOLOGY) · Dermatology Physician · Student in an Organized Health Care Education/Training Program · NEW YORK, NY
- NPI 1346772472
- Accepts Medicare
- 9 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
5 E 98TH ST
NEW YORK, NY 100296501
(212) 241-9728 - Additional location
-
2900 N Lake Shore Dr, Presence Saint Joseph Hospital Chicago
Chicago, IL 606575640
(773) 665-6730
Credentials & registration
- NPI registered
- March 2017 — 9 yrs on file
- Profile last updated
- March 8, 2022
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- New York #315156-01 · Illinois #125.071016
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346772472. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
708
Distinct HCPCS
8
Medicare allowed
$55,753
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 185 | 43 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 170 | 133 | $103 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 97 | 97 | $129 | |
17000 |
Destruction of precancer skin growth, 1 growth | 80 | 66 | $63 | |
11102 |
Biopsy of related skin growth, first growth | 70 | 61 | $110 | |
11103 |
Biopsy of related skin growth, each additional growth | 39 | 21 | $59 | |
17110 |
Destruction of skin growth, 1-14 growths | 35 | 33 | $133 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 32 | 28 | $145 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 3.9× the peer median.Open Payments
Industry payments received
All-time total
$1,221
Transactions
42
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 13 | $485.76 | |
| Galderma Laboratories, L.P. | 4 | $152.29 | |
| Dermavant Sciences, Inc. | 6 | $100.91 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $94.57 | |
| Lilly USA, LLC | 3 | $80.66 | |
| Incyte Corporation | 3 | $66.76 | |
| Janssen Biotech, Inc. | 3 | $62.92 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $53.15 | |
| UCB, Inc. | 1 | $46.04 | |
| GENZYME CORPORATION | 2 | $44.55 | |
| Arcutis Biotherapeutics, Inc. | 2 | $33.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
205
Patients
143
Total drug cost
$4,369
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 76 | 49 | $2,000 |
| Triamcinolone Acetonide | Generic | 60 | 47 | $706 |
| Clobetasol Propionate | Generic | 26 | 17 | $1,206 |
| Mupirocin | Generic | 22 | 13 | $197 |
| Hydrocortisone | Generic | 21 | 17 | $259 |